6. Pharmaceuticals. Below are the incremental cash flows for the Canopy project for you to use in your analysis. Assume Canopy's marginal tax rate is 35%, their cost of capital is 15.7 % and an expected growth rate of 5% after 2003. You are considering a geographic expansion into the European market for Canopy 1998 1999 2000 2001 2002 2003 Net Sales 8,500 15,000 35,500 46,000 52,000 60,000 Cost of Sales 3,100 5,500 13,900 18,000 20,000 24,400 Depreciation 100 100 100 100 100 100 SG&A 3,500 5,410 6,400 5,300 7,200 7,800 7,000 R&D 1,100 2,800 4,100 5,400 6,500 EBIT 700 1,190 11,000 17,200 18,200 20,700 Income Tax (35%) 245 417 3.850 6,020 6,370 7,245 455 774 Net Earnings Depreciation Operating Cash Flows 7,150 11,180 11,830 13,455 Net PPE (906) (1394) (900) (800) (300) (200) Working Capital (2,030) (780) (2457) (1267) (738) (912) Terminal Value Free Cash Flows

Essentials Of Investments
11th Edition
ISBN:9781260013924
Author:Bodie, Zvi, Kane, Alex, MARCUS, Alan J.
Publisher:Bodie, Zvi, Kane, Alex, MARCUS, Alan J.
Chapter1: Investments: Background And Issues
Section: Chapter Questions
Problem 1PS
icon
Related questions
Question

What is the free cash flow and terminal value of the Canopy project in 2003?

Certainly! Below is the transcription and explanation suitable for an educational website:

---

**Geographical Expansion Financial Analysis for Canopy Pharmaceuticals**

You are considering a geographical expansion into the European market for Canopy Pharmaceuticals. Below are the incremental cash flows for the Canopy project for analysis. Assume Canopy’s marginal tax rate is 35%, their cost of capital is 15.7%, and an expected growth rate of 5% after 2003.

| Year  | 1998 | 1999 | 2000 | 2001 | 2002 | 2003 |
|-------|------|------|------|------|------|------|
| **Net Sales** | 8,500 | 15,000 | 35,500 | 46,000 | 52,000 | 60,000 |
| **Cost of Sales** | 3,100 | 5,500 | 13,900 | 18,000 | 20,000 | 24,400 |
| **Depreciation** | 100 | 100 | 100 | 100 | 100 | 100 |
| **SG&A** | 3,500 | 5,410 | 6,400 | 5,300 | 7,200 | 7,800 |
| **R&D** | 1,100 | 2,800 | 4,100 | 5,400 | 5,600 | 7,000 |
| **EBIT** | 700 | 1,190 | 11,000 | 17,200 | 18,200 | 20,700 |
| **Income Tax (35%)** | 245 | 417 | 3,850 | 6,020 | 6,370 | 7,245 |
| **Net Earnings** | 455 | 774 | 7,150 | 11,180 | 11,830 | 13,455 |
| **Depreciation** | - | - | - | - | - | - |
| **Operating Cash Flows** | - | - | - | - | - | - |
| **Net PPE** | (906) | (1,394) | (900) | (800) | (300) | (200) |
| **Working Capital** | (2,030) | (780) | (2,457) | (1,
Transcribed Image Text:Certainly! Below is the transcription and explanation suitable for an educational website: --- **Geographical Expansion Financial Analysis for Canopy Pharmaceuticals** You are considering a geographical expansion into the European market for Canopy Pharmaceuticals. Below are the incremental cash flows for the Canopy project for analysis. Assume Canopy’s marginal tax rate is 35%, their cost of capital is 15.7%, and an expected growth rate of 5% after 2003. | Year | 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | |-------|------|------|------|------|------|------| | **Net Sales** | 8,500 | 15,000 | 35,500 | 46,000 | 52,000 | 60,000 | | **Cost of Sales** | 3,100 | 5,500 | 13,900 | 18,000 | 20,000 | 24,400 | | **Depreciation** | 100 | 100 | 100 | 100 | 100 | 100 | | **SG&A** | 3,500 | 5,410 | 6,400 | 5,300 | 7,200 | 7,800 | | **R&D** | 1,100 | 2,800 | 4,100 | 5,400 | 5,600 | 7,000 | | **EBIT** | 700 | 1,190 | 11,000 | 17,200 | 18,200 | 20,700 | | **Income Tax (35%)** | 245 | 417 | 3,850 | 6,020 | 6,370 | 7,245 | | **Net Earnings** | 455 | 774 | 7,150 | 11,180 | 11,830 | 13,455 | | **Depreciation** | - | - | - | - | - | - | | **Operating Cash Flows** | - | - | - | - | - | - | | **Net PPE** | (906) | (1,394) | (900) | (800) | (300) | (200) | | **Working Capital** | (2,030) | (780) | (2,457) | (1,
Expert Solution
trending now

Trending now

This is a popular solution!

steps

Step by step

Solved in 2 steps

Blurred answer
Knowledge Booster
Capital Budgeting
Learn more about
Need a deep-dive on the concept behind this application? Look no further. Learn more about this topic, finance and related others by exploring similar questions and additional content below.
Similar questions
  • SEE MORE QUESTIONS
Recommended textbooks for you
Essentials Of Investments
Essentials Of Investments
Finance
ISBN:
9781260013924
Author:
Bodie, Zvi, Kane, Alex, MARCUS, Alan J.
Publisher:
Mcgraw-hill Education,
FUNDAMENTALS OF CORPORATE FINANCE
FUNDAMENTALS OF CORPORATE FINANCE
Finance
ISBN:
9781260013962
Author:
BREALEY
Publisher:
RENT MCG
Financial Management: Theory & Practice
Financial Management: Theory & Practice
Finance
ISBN:
9781337909730
Author:
Brigham
Publisher:
Cengage
Foundations Of Finance
Foundations Of Finance
Finance
ISBN:
9780134897264
Author:
KEOWN, Arthur J., Martin, John D., PETTY, J. William
Publisher:
Pearson,
Fundamentals of Financial Management (MindTap Cou…
Fundamentals of Financial Management (MindTap Cou…
Finance
ISBN:
9781337395250
Author:
Eugene F. Brigham, Joel F. Houston
Publisher:
Cengage Learning
Corporate Finance (The Mcgraw-hill/Irwin Series i…
Corporate Finance (The Mcgraw-hill/Irwin Series i…
Finance
ISBN:
9780077861759
Author:
Stephen A. Ross Franco Modigliani Professor of Financial Economics Professor, Randolph W Westerfield Robert R. Dockson Deans Chair in Bus. Admin., Jeffrey Jaffe, Bradford D Jordan Professor
Publisher:
McGraw-Hill Education